Outcome of XXXX in 52 adults.

@entity1 @entity410 @entity1032 @entity2695 @entity146 @entity3932 @entity16 @entity245 @entity726 @entity51 @entity4848 @entity2916 @entity3809
@entity3932 ( @entity3932 ) is a @entity4848 characterized by cutaneous @entity2695 , @entity2695 associated with @entity410 and other @entity16 including @entity1032 , and @entity726 . Only limited information about long-term outcome, including the societal integration of adult @entity1 , is available in the literature. Data on 52 adults with @entity3932 , ages 18-63 years, ascertained through the Sturge-Weber Foundation, were obtained via written questionnaires, telephone interviews, and reviews of medical records. The distribution of @entity3809 (cranial 98%, extracranial 52%) and the prevalences of @entity726 (60%), @entity410 (83%), @entity51 (65%), and other complications were established. The age of onset of @entity726 (0-41 years), the age of onset of @entity410 (0-23 years), and the correlation between the distribution of @entity3809 and the prevalence of @entity410 was identified. The relationship between the age of onset of @entity410 and @entity410 control was established. In those with and without @entity410 , the prevalences of @entity245 (43% vs. 0%), emotional and @entity146 (85% vs. 58%), special education requirements (71% vs. 0%), and employability (46% vs. 78%) were analyzed. Overall, 39% were financially self-sufficient, and 55% were or could be married. Ten @entity1 produced 20 liveborn offspring; 17 were healthy, and @entity2916 , a caf  -au-lait spot, and a "birthmark" were found in 1 @entity1 each. The results of this study can be used for genetic counseling in @entity3932 .
